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Introduction 
Cancer, one of  the leading causes of  human death, has attracted 
more attention due to the complexity of  etiology, diagnosis and 
treatment [1]. In recent years, chemotherapeutic management 
against various types of  cancer including leukemia has been in-
creased rapidly though some times cancer cells resistance against 
chemotherapy [2, 3]. In this respect, search for effective antican-
cer agent that inhibit the proliferation of  the cells as well as inhibit 
the resistance nature of  the cancer cells and induce differentiation 
of  the monocytes is an ongoing challenge. Therefore to find out 
anticancer agent with multi-target efficacies, attention has been 
focused on plant products as the plant products have been used 
as remedies for several human diseases including cancer from 
ancient times with lower side effects [4]. The reasons for using 
them that they contain variety of  chemical compounds usually 
secondary metabolites with therapeutic values [5]. Cestrum parqui 
is belonging to the family Solanaceae, usually known as “green or 
Chilean cestrum” in Tunisia, are rich in various secondary me-
tabolites such as saponins, polyhydroxylated terpenes (C13 nor-
isoprenoids, sesquiterpenes, spirostanes and pseudosapogenins) 
and ent-kaurene glycosides (parquin and carboxyparquin) [6-8]. 
Several scientific reports demonstrate that C. parqui exhibits a 
wide spectrum of  pharmacological activity when administered 
systemically or in isolated organ preparations. For example, it is 
used to treat headache, rheumatic pain, scabies, dermatosis, diar-
rhaea and metrorraghia [7]. The plant is also used in Chilean folk 
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medicine as antifebrile and for the treatment of  fever and inflam-
mation [8] though there is no information about the anticancer 
efficacy of  this plant.
In the present study, anticancer activity of  leaves of  C.  parqui was 
investigated on human myeloid leukaemia cell line (HL-60). For 
this purpose, first methanol extract of  C. parqui leaves was frac-
tioned by column chromatography followed by all the fractions 
were examined on cell line (HL-60). Simultaneously an attempt 
was taken to identify the biologically active compounds from the 
effective fraction responsible for anticancer activity.
Methods and Materials
Preparation of  the methanolic extract
The leaves of  C. parqui were collected from the National Institute 
of  Agronomy Garden, Tunisia. Collected seeds were dried in a 
steam room at 40°C for 3 days followed by ground into powder 
form. The powdered material was extracted in methanol for 7 days 
and it was repeated for three times. Then the collected methanolic 
phases were combined and the residue was removed by filtration. 
The filtrate was concentrated under reduced pressure by rotary 
evaporator to obtain methnolic Extract (ME).  This extract was 
subjected to column chromatography using silica gel as the sta-
tionary phase and eluted by solvents as per increasing polarity i.e. 
CH2Cl2-MeOH (20:1→0:1). Seventy fractions (100mL each) were 
collected and based on their thin layer chromatographic (TLC) 
profiles fractions were combined and ultimately eight pooled frac-
tions (F-I to F-VIII) were obtained. Finally, entire pooled fraction 
was concentrated separately under reduced pressure and the resi-
due was used for bioactivity study.
Bioactivity Study
Cell culture and treatments
HL-60 cell line was cultured in RPMI-1640 medium containing 
10% (v/v) heat-inactivated fetal bovine serum, 100units/mL pen-
icillin and 100μg/mL streptomycin under 5% CO2-95% air hu-
midified incubator at 37°C. The cell numbers were counted using 
Neubauer’s counting chamber and the viability was determined by 
trypan blue (0.025%) exclusion method.
Dilutions of  each fraction were performed just before used in the 
culture media using 0.5 % dimethyl sulfoxide (DMSO). The cells 
were treated in triplicate manner with various concentrations of  
each fraction. In control, only 0.5 % DMSO was used as the said 
concentration is non toxic to the cells.
Cell proliferation analysis
Analysis of  cell proliferation in fraction treated as well as in con-
trol cells was carried out by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-di-
phenyl tetrazolium bromide (MTT) assay [9].
Cell apoptosis rate determination by Quantitative Nuclear 
Fluorescence Morphology (QNFM) assay
The morphological changes in the cells were assessed by Hoechst 
staining under fluorescent microscope. For this purpose, 5x105 
HL-60 cells/well were plated in 6 well plates. After 24h of  treat-
ment with 30µg/mL of  fraction II, the cells were harvested and 
fixed in 3% paraformaldehyde followed by incubation at room 
temperature for 10 min. The cells were washed in phosphate buff-
er saline (PBS) and incubated for 15 min at room temperature in 
50µL of  PBS containing 20µg/mL bis-benzimide trihydrochlo-
ride (Hoechst 33258). 
Finally, 10 µL aliquots of  the cells were placed on glass slides and 
500 cells were counted and scored for the incidence of  apoptotic 
chromatin condensation in triplicate samples under Zeiss fluores-
cent microscope.
Cell cycle analysis
Alteration of  the cell DNA content, histogram measurements of  
hypodiploid DNA formation was carried out by flow cytometer 
using EPICS™ cytometer-Beckman Coulter [10].
In brief, cells were treated with 30µg/mL of  fraction II for 24 
h followed by harvested, washed and fixed with ice-cold 75 % 
ethanol for 1h. The cells were centrifuged, pellets were suspended 
in PBS and treated with RNase A at the concentration of  100 
µg/mL. Propidium iodide at the concentration of  50µg/mL was 
added to the sample and kept in dark for 30 min to stain DNA. 
For each determination 10, 000 cells were counted and the cells 
with decreased DNA staining composed of  apoptotic cells were 
expressed in terms of  percentage (%). Histograms were analyzed 
with the Expo 32 ADC Software™.
DNA fragmentation analysis
The isolation of  fragmented DNA was carried out according to 
standard protocol [9]. Cells were harvested and washed with PBS 
and pelleted by centrifugation. Then the pellets were treated with 
30µL of  lysis buffer (50 mM Tris-HCl, pH 8.0) containing 10 mM 
EDTA, 0.5% SDS, 1 µg/µL RNase (Sigma) for 1 h at 37°C. Fi-
nally 3µL of  proteinase K (10µg/µL) was added and the mixture 
was incubated for 1h at 50°C.
DNA was extracted with 150µL of  phenol-chloroform-isoamyl 
alcohol (24:24:1) and dissolved in loading buffer (10mM EDTA, 
pH 8.0, 40% sucrose and 0.25% bromophenol blue). Aliquot was 
loaded on 1.8% agarose gel, stained with ethidium bromide and 
the expression of  DNA fragments were observed under UV il-
lumination.
Instrumental Analysis
Analytical HPLC
The fractions were analyzed by high performance liquid chroma-
tography with diode array (HPLC-DAD) using a Hitachi Lachrom 
Elite HPLC system (San Jose, CA USA) equipped with a qua-
ternary pump, auto sampler, in-line degassing unit, temperature 
control unit, photo-diode array UV detector and fitted with an 
analytical column Kromasil C18 (Teknokroma, Barcelona, Spain) 
(25 × 0.4 cm i.d., 100-Å, 5-μm particle size). Acquisitions were 
made using EZChrom Elite 3.1.3 from Scientific Software Inc. 
(Pleasanton, CA, USA). Load: 40 µL, 10 µg. Elution: [A] 0.1% 
(v/v) aqueous TFA, [B] 0.08% (v/v) TFA in water/CH3CN 1:4, 
gradient 12 to 30 % [B] over 30 min at the flow rate of  1mL/min. 
DAD detection was performed from at 210 to 380 nm. Data were 
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acquired in triplicate.
LC-PDA-ELSD analysis
The HPLC work was performed on an Alliance 2695 apparatus 
coupled with a 996 UV diode array detector (Waters Corporation, 
Milford, MA, USA) together with Polymer Laboratories (Am-
herst, MA, USA) PL-ELS 1000 evaporative light scattering (ELS) 
detector. Fractions were collected on a Waters fraction collector 
III (Waters Corporation). A column Kromasil C18 (Teknokroma, 
Barcelona, Spain) (25 × 0.4 cm i.d., 100-Å, 5-μm particle size) 
was used as stationary phase. The mobile phase consist of  wa-
ter (0.1% acetic acid) (A) and methanol (B) at the flow rate of  
1 mL/min and the injection volume was 100 µL. Analysis was 
carried out using the following gradient elution: 0-20min:80%B, 
20-40min:100% B. The method of  ELS detector was set up as 
follows: Gas flow was 1.5 L/min, Nebulizer temperature: 90°C, 
Evap. temperature: 120°C and the detection wavelength was 254 
nm.
Prep-HPLC
Preparative RP-HPLC was performed on a Waters Prep LC 
pumping system (Milford, MA) equipped with Waters 2489 UV/
Vis detector and X-Terra Prep MS C18 column (Waters). Separa-
tion was done using the same gradient elution as in HPLC-PDA-
ELSD conditions. Flow rate was 10mL/min, detection wave-
length 254 nm and injection volume was 20μL.
Derivatization of  purified compound
The derivatization of  the compound was carried out according to 
standard method [11]. In brief, 0.2µg of  purified compounds were 
derivatized by adding 100µL of  silylation reagent N-methyl-N-tri-
methyl silyl tri-fluoro acetamide (MSTFA) and 50µL of  pyridine. 
The reaction mixture was kept for 2 h at 70°C. After removing 
the solvents, 5µL of  tetrahydrofuran (THF) was added followed 
by 1µL of  the solution was injected into the gas chromatography 
coupled to mass spectrometry (GC-MS).
GC-MS conditions
GC-MS analysis was carried out using BD-5 capillary column 
where flow rate was 1mL/min. The system was operated under 
the following conditions: injection temperature, 290°C; transfer 
line temperature, 300°C; oven temperature program, 60 (l), and 
rate 12°C/min; final temperature, 320°C. The mass spectrometer 
was monitored to scan 40-800 uma with an ionizing voltage at 
70eV.
Statistical analysis
Statistical comparison between the groups was done by student’s 
t test using software STATISTICA. Differences between the 
groups were considered significant when p<0.05.
Results
Cell proliferation analysis
Effect of  different fractions (I-VIII) on the viability of  HL-60 
cells was measured by MTT assay. After 72h, the viability of  
HL-60 cells was reduced more than 50% when HL-60 cells were 
treated with fractions (I-IV) at the dose of  100µg/mL. Though, 
the cell viability was increased more than 100% when the cells 
were treated with fractions (V-VIII). This data suggested that only 
fractions (I-IV) were effective in the inhibition of  HL-60 cell pro-
liferation (Figure1A).
According to the National Cancer Institute (NCI), plant extracts 
and pure compounds with cytotoxic ED50 (Effective Dose 50) 
values ≤30µg/mL and ≤40µg/mL, respectively, are considered 
active [12]. Therefore, further MTT test was carried out using 
the fractions I-IV at lower dose i.e. 30 µg/mL to search out the 
threshold dose in this concern. The result indicated that the frac-
tions II was most active whereas fractions (I, III and IV) showed 
moderate activity in this purpose (Figure1B).
Result focused that fraction III at the dose of  100μg/mL is more 
efficient than Fraction II   (Figure 1A). But, this is not applicable 
at the dose of  30µg/mL (Figure 1B) which may be the difference 
in composition of  these two fractions.
Cell apoptosis rate determination by QNFM assay
For the determination of  apoptosis, HL-60 cells were treated with 
30µg/mL of  each active fraction (I, II and III) and analyzed by 
light microscopy. Fraction II treated cells showed the presence of  
more number of  apoptotic cells in respect to control (Figure 2, 
Figure 2A control and Figure 2B cells treated with 30µg/mL of  
fraction II) which also supports the results obtained by MTT test. 
So, the results obtained by MTT test and light microscopy analysis 
Figure 1. Effect of  each fraction of  ME of  C. parqui leaf  extract on the viability of  HL-60 cell cells. (A) Cells were cul-
tured in presence of  100 µg/mL of  each fraction for 72 h. (B) Cells were cultured in presence of  30µg/mL of  each fraction    
(I-IV) for 72 h.
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indicated that fraction II is the most potent to induce apoptotic 
cell death.
Fluorescence microscopic observation after Hoechst 33258 stain-
ing of  fraction II treated HL-60 cells showed that the control cells 
were uniformly blue and the apoptotic cells  were blue having 
bright blue dots in their nuclei, representing the apoptotic bodies 
(nuclear fragmentation) (Figure 3A). Indeed, fraction II resulted 
dose-dependent increase in apoptotic-death of  cells during 24h 
(Figure 3B).
Cell cycle analysis
To explain the observed inhibition in proliferation, cell cycle dis-
tribution after 24 h of  fraction treatment was studied. Cell cycle 
analysis by flow cytometry showed that nuclei in apoptotic cells 
decreased the DNA stain ability with PI, indicated by the appear-
ance of  a sub-G1 peak on the DNA histogram (Figure 4A).  This 
result further converted into numeral histogram, shows the flow 
cytometry analysis on HL-60 cells stained with PI for 24h (Figure 
4B). The apparition of  sub-G1 peak was observed in 20% of  
the fraction II treated cells, which is 4 fold more than untreated 
control cells.
DNA fragmentation analysis
Programmed cell death is another phenomenon that could ex-
plain inhibition in cell proliferation by analysis of  DNA fragmen-
tation, the latest stage of  apoptosis. After 24h treatment, result 
showed that fraction II induced DNA fragmentation in HL-60 
cells (Figure 5).
HPLC-PDA–ELSD
In the light of  the results of  QNFM, cell cycle and DNA frag-
mentation, fraction II showed most potent activity and induces 
apoptotic cell death on HL-60 cells. On that background, chro-
matographic analysis was carried out only for fraction II.
Thin layer chromatographic analysis (Si-gel, CH2Cl2/MeOH, 
20/1) of  fraction II showed the presence of  two major con-
stituents. Then an attempt was directed to check the purity of  
fraction-II using HPLC-UV but, unfortunately, this method was 
unsuitable due to the weak absorbance of  the compounds by UV. 
Therefore, the HPLC-ELSD technique was adopted. The ELSD 
chromatograms of  fraction II showed 2 peaks, one low intense 
peak at 16 min and another one more intense at 16.5 min which 
confirms the presence of  two compounds (Figure 6).
Identification by GC-M
After purification by preparative HPLC, two compounds were 
analysed by GC-MS (Figure 7) and the results indicated the pres-
ence of  three compounds, two known compounds are pentacyclic 
triterpenoids: oleanolic and ursolic acids and for identification of  
Figure 2. Morphologic changes of  HL-60 cells observed under optical microscopy (X400) (A) Control i.e. cells without 
treatment (B) Cells treated with fraction II at 30 µg/mL for 24 h.
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Figure 3. Effect of  fraction II on apoptosis induction in human leukemia cells. (A): Photomicrographs of  representative 
fields of  cells stained with Hoechst 33258 to evaluate nuclear chromatin condensation (i.e. apoptosis) after treatment with 
fraction II for 24 h. (B) Cells were treated with different concentrations of  fraction II and  % of  apoptotic cells was evalu-
ated by fluorescent microscopy. Values represent means ± SE of  three independent experiments (each performed in tripli-
cate).  *P <0.05, significantly different from untreated control.
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Figure 4. Determination of  sub-G1 cells in fraction II treated HL-60 cells. (A) Cells treated with 30µg/mL of  fraction II 
and subjected to flow cytometry after propidium iodide staining. Hypodiploids cells (apoptotic cells) are shown in region 
marked with an arrow. (B): Cells were incubated as above and apoptotic cells were quantitated as percentage of  cells in sub 
G1 region.
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other compound need more investigation. The structural elucida-
tion of  ursolic acid (UA) and oleanolic (OA) isomers were carried 
out by comparison of  experimental values from GC-MS with pre-
viously reported values [11].
Discussion
Present study demonstrate that C. parqui leaves possess antican-
cer activity on HL-60 cell line. Chromatographic separation of  
the said extract was given eight fractions, out of  which fraction 
II showed most potent efficacy in this concern. Phytochemical 
analysis of  this fraction indicated that the actives compounds are 
oleanolic acid (OA) and ursolic acid (UA). These two compounds 
are pentacyclic triterpenoids having a similar chemical structure 
and are the major components of  many medicinal plants and 
herbs widely distributed all over the world and these components 
have attracted a lot of  attention because of  their various biologi-
cal activity such as anti-inflammatory, antioxidant, hepatoprotec-
tive, cytotoxic, antitumor and antiangiogenis [13-18]. So the pro-
apoptotic effect of  fraction II is not very surprising event because 
the presence of  these antitumor compounds [19] but it’s mecha-
nism of  actions  needs to more investigation. In the present study, 
it was found that 30µg/mLof  fraction II inhibit cell proliferation 
and induced apoptotic cell death and the death is characterized 
by formation of  apoptotic bodies, DNA fragmentation and cell 
cycle arrest in subG1 phase. To understand the pathway of  apop-
totic cell death, results were compared with the literature and two 
major pathways of  apoptotic cell death program have been identi-
Special Issue on "Apoptosis & Cancer Science"
Figure 7. Profile obtained by gas chromatography coupled to mass spectrometry. (A) Total ion chromatograms (TIC) of  si-
lylated investigated compound purified by HPLC-prep. (B) Typical EI mass spectra of  TMS derivateives of  oleanolic acid. 
(C) Typical EI mass spectra of  TMS derivateives of  ursolic acid.
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fied, namely receptor-mediated (extrinsic) and chemical-induced 
mitochondrial (intrinsic) apoptosis [20]. Zhang, et al. [21] report-
ed that OA induced apoptotic cell death  on HL-60 cell lines and 
the apoptotic death is characterized by formation of  apoptotic 
bodies, DNA fragmentation, increased of  the number of  cell in 
the sub G1 phase, activation of  caspase 3 and 9 and cleavage of  
poly (ADP ribose) polymerase and Takashi et al. [22] reported 
that OA inhibit the DNA topoisomerase, so the pathway of  ap-
optotic death is extrinsic. Concerning the apoptotic effect of  UA 
on HL-60, Beak et al. demonstrated that UA induced genomic 
DNA fragmentation, a hallmark of  apoptosis, indicating that the 
mechanism by which UA induced cell death was through apopto-
sis [23]. They also demonstrated that UA induce the intracellular 
ca2+ release  which may be involved in UA induced apoptosis in 
HL-60 cells [23]. So there is not much work regarding the mecha-
nism of  action of  UA  in the induction of  apoptosis in HL-60 
cells though several studies on other cell line such as gastric can-
cer cell line BGC-803, HT-29, HepG2 human hepatoblastoma 
cell, human breast cancer cell line MDA-MB-231 [24-28].
Taken together the results, it may be suggest that the fraction II 
enriched with OA and UA induced the death via extrinsic pathway 
due to the dominance of  the OA in these fraction as shown in the 
profile of  GC-MS.
It is known that the mixture of  OA and UA has a higher activ-
ity than individual compound but the compared with the litera-
ture, 30µg/mL of  fraction II is more higher than OA and UA 
separately because EC50 of  OA was 8.1µM and UA was 5.0µM 
[24]. This may be due to the presence of  the other compound at 
low concentration but it may have antagonist activity to the OA 
and UA at this lower dose. Identification of  the third compound 
needs further investigation.
One of  the major side effects in the effective treatment of  human 
malignancies is the acquisition of  broad anti-cancer drug resist-
ance by tumor cells. This phenomenon has been termed ‘‘multid-
rug resistance (MDR)’’. Therefore, development of  new modula-
tor for inhibition of  drug resistance is required [29, 30]. So, to find 
out an effective drug that removes drug resistance from tumors, 
Shan Jian [31] demonstrated that OA and UA displayed signifi-
cant inhibitory effects on HL-60 and HL60/ADR cells. Their cell 
proliferation inhibiting curves on parents cells and MDR cells of  
acute and chronic myelocytic leukemia were basically the same, 
the multiple of  drug resistance being 1, suggesting that UA and 
OA are not the substrate of  the drug pump proteins [31]. As a 
result they could not pumped out of  the cells when entering and 
thus they were capable of  displaying their implicit effect.
Furthermore, acute myeloid leukemia (AML) is characterized by 
a block in differentiation that leads to the accumulation of  im-
mature cells. So, the induction of  differentiation is becoming the 
ideal theurapeutic strategy in a substrat of  AML [32]. Alongside, 
UA was found to be an effective inducer of  monocytic differen-
tiation of  HL-60 cells [33]. Taking together the results in the pre-
sent study as well as previous findings, it may be assumed that OA 
and UA are important agents in the treatment of  AML leukemia.
Conclusion
Finally, it was concluded that this is the first report about the ex-
istence of  biologically active phytomolecules namely OA and UA 
in C. parqui leaves. These two phytomolecules exert anticancer ac-
tivities on HL-60 cell line by two ways; one is apoptosis induction 
and other is inhibition in cell cycle. These two phytomolecules 
may be used as chemotherapy for certain cancer in future after 
extensive work in this line.
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